ESC Professional Premium Access

How to treat HFpEF in 2022 and beyond

Event: ESC Congress 2022
Topic: Chronic Heart Failure
Session type: Advances in Science
Date: 29 August 2022
Time: 14:00 - 15:15

Congress Session

Become an ESC Professional member to access this resource

Become a member

Already a member? Sign in

4 presentations in this session

Treating HFpEF: State of the art 2022

Speaker: Professor S. Solomon (Boston, US)
Thumbnail

Efficacy of empagliflozin in patients with heart failure according to baseline KDIGO risk categories - findings from the EMPEROR-Pooled

Speaker: Professor J. Butler (Jackson, US)
Thumbnail

Efficacy and safety of sacubitril/valsartan according to frailty in heart failure with preserved ejection fraction: a post hoc analysis of the PARAGON-HF trial

Speaker: Doctor J. Butt (Copenhagen, DK)
Thumbnail

Digoxin improves systolic cardiac function in patients with AF and HFpEF: the RATE-AF randomised trial

Speaker: Doctor K. Bunting (Birmingham, GB)
Thumbnail

4 speakers from this session

Professor Scott Solomon

Brigham And Women'S Hospital, Harvard Medical School, Boston (United States of America)
43 presentations
12 followers

Professor Javed Butler

The University of Mississippi Medical Center, Jackson (United States of America)
71 presentations
5 followers

Doctor Jawad Haider Butt

Rigshospitalet - Copenhagen University Hospital, Copenhagen (Denmark)
0 follower

Doctor Karina V Bunting

University of Birmingham, Birmingham (United Kingdom of Great Britain & Northern Ireland)
0 follower

This platform is supported by

logo Novo Nordisk